CN102599502B - Healthcare product with weight reducing function and preparation method of healthcare product - Google Patents
Healthcare product with weight reducing function and preparation method of healthcare product Download PDFInfo
- Publication number
- CN102599502B CN102599502B CN2012100670428A CN201210067042A CN102599502B CN 102599502 B CN102599502 B CN 102599502B CN 2012100670428 A CN2012100670428 A CN 2012100670428A CN 201210067042 A CN201210067042 A CN 201210067042A CN 102599502 B CN102599502 B CN 102599502B
- Authority
- CN
- China
- Prior art keywords
- extract
- chia
- oat
- grape
- following methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a healthcare product with a weight reducing function and a preparation method of the healthcare product. The healthcare product comprises raw materials including, by weight, from 20 to 40 parts of chia extracts, from 20 to 30 parts of oat extracts, from 5 to 15 parts of grape extracts, from 5 to 15 parts of coarse old tea extracts, from 5 to 15 parts of sea-tangle extracts and from 10 to 20 parts of water-soluble modified corn starch. Compared with the prior art, the healthcare product with the weight reducing function and the preparation method of the health product have the advantages that a weight reducing formula is designed by a multilink and multi-garget-position synergistic effect mode, so that the healthcare product strives to achieve a good weight reducing effect, and meets a weight reducing principle that diarrhea, starvation diet and weakness are avoided suggested by the world health organization.
Description
Technical field
The present invention relates to a kind of health product and preparation method thereof, especially relate to a kind of health products with weight losing function and preparation method thereof.
Background technology
Last to twentieth century after World War II, develop rapidly due to science, the improvement of material life condition and dietary structure unreasonable, obesity spread as the pestilence in developing country that developed country and economy develop rapidly comes, and the incidence of disease is soaring year by year.It is estimated, the obesity patient has 1,200,000,000 at present at least in the world.At US and European, the obese patient rolls up.U.S. obese patient accounts for 1/2nd of total population, causes annual 300000 people dead.Director Fei Li doctor James of problem of obesity special group of World Health Organization prediction, world fat person number will increase with every 5 years speed of a times.Obesity and AIDS, malicious anaesthetic addiction and alcoholophilia are listed as the large medical science social concern in the world four, are the formidable enemies of human health longevity.Medical circle also calls the coronary heart disease relevant with obesity, hypertension, hyperlipidemia, diabetes, cerebrovas-cularaccident " dead quintet ".Therefore, China Ministry of Public Health points out: adopting an effective measure, scientifically prevent and treat obesity, become the focus of current external common concern, is also the new problem of pendulum in face of China's medical circle.
China obese patient has surpassed 7,000 ten thousand people (not comprising children obesity), accounts for 5.4% of total population.Along with reform and opening-up and the improvement of terms of people's material life, the positive increase year after year of obesity patient take the big and medium-sized cities incidence of disease as high, accounts for 17% of urban population especially.In big cities such as Beijing, Shanghai, adult's overweight of nearly 1/3rd becomes the district occurred frequently of obesity.And over past ten years, the children obesity recall rate increases by 9% left and right every year on average, this means that the quantity of China's Obese children after 10 years will be than now Duoing one times.
The fewer reason of slimming medicine is most of slimming medicines at present, the side effect of varying degree is arranged as appetite inhibitor, diuretics, cathartic etc., and the nineties, two novel slimming drugs orlistats, the sibutramine of later development brought Gospel with its definite curative effect, less side effect to the obesity patient.
(1) external slimming medicine market
Foreign study shows, a kind of CLA (CLA) can impel Preadipocyte dead, reaches the growth of obvious inhibition adipose tissue.CLA prevents in addition and treats cancer, prevents coronary heart disease and improves glycometabolic effect.Still be in conceptual phase as medicine CLA at present, the gone on the market health products of the multiple CLA of containing composition of the U.S..In addition, CLA is at dairy produce, and is as abundanter in content in cheese, sour milk.
Sibutramine obtains FDA Food and Drug Administration's approval in November, 1997 in U.S.'s listing by Germany (Ke Nuo) KNOLL pharmaceutical factory exploitation, is European ﹠ American Market fat-reducing medicine salable the earliest.The sales volume of sibutramine hydrochloride 1999 states reaches 400,000,000 dollars.The antiadipositas drug orlistat of Switzerland Roche Holding Ag was obtained good achievement in 1999, even before in May, 1999, it is not yet in main American market listing, sales volume has reached nearly 6.5 hundred million dollars.
U.S.'s antiadipositas drug market in 1999 is mainly promoted by the orlistat of new drug Roche Holding Ag and the sibutramine of KNOLL company.In 12 months of 7 the end of month in 1999, increase by 11% with regard to obesity to the medical number in American physician clinic, reach 7,100,000 people.After sibutramine went on the market 4 months in January, 1998, the fat new recipe for the treatment of reached 560,000.Orlistat listing subsequently, the one new recipe of individual month has reached 63.7 ten thousand.July in the same year, orlistat accounted for 23% of obesity product new recipe number, and sibutramine occupies second.That sibutramine is taken in the whole world at present is 3,000,000 people, and that take orlistat is 8,000,000 people, has occupied the first two position of slimming medicine sales volume.But, since nearly 5 months, total recipe quantity of orlistat has descended 14%, and meanwhile, the recipe quantity of sibutramine but rises gradually, and reason is to find that orlistat affects the absorption of fat-soluble A, E.
(2) domestic slimming medicine (product), health-product market
The proposition of this concept of losing weight is only about ten years thing in China, and diet products are through having walked the renewal course of develop rapidly.The mid-90, when the fat-reducing idea just had been familiar with by people, many producers had just captured this information and have recognized that diet products will have very large market and fine prospect, and market Ri Xinwan is different for weight-reducing product, update speed is accelerated day by day, has experienced twice product renewal.
The first generation is rushed down clearly the type diet products and mostly traditional slim tea is improved, and utilizes the tealeaves esterified greasy effect of dispelling to lose weight.In order to embody the effect of quick weight-lossing, the cathartic that some producers have added dosage not wait in slim tea is as Chinese herbal medicines such as rheum officinale, saltcake and sennaes, by moisture content and the protein in the mode human body of diarrhoea, what cause is the illusion that loses weight, and but the basic of obesity can be touched in the end.These slim teas of long-term taking also can cause damage to function of human body, the symptoms such as habitual diarrhea, gastrointestinal dysfunction and human body dehydration occur.
The hungry substituted type diet products of the second generation reach the fat-reducing purpose by " going on a diet ", namely replace normal diet with low-calorie diet, to reduce human body, the absorption of fat, carbohydrate, the consumption of dependence human body own fat are come makeup energy.In order to cause the sensation of " having had enough ", also add the medicines (inactive in the U.S. at present) such as appetite inhibitor fenfluramine, An Feila ketone in some substituted type diet food.Long-term use can make health be in starvation, has not only reduced the mobility of body each side, in case cut out, body weight just can quick rebound.
The third generation health type diet food World Health Organization proposes does not suffer from diarrhoea, does not go on a diet and not weakly is the fat-reducing principle, and effect increases than the first generation, second generation diet products.
Due to the develop rapidly of science, the improvement of material life condition and dietary structure unreasonable, obesity spreads as the pestilence in developing country that developed country and economy develop rapidly and comes, and the incidence of disease is soaring year by year, and rejuvenation situation occurs.Whole world obesity patient has 1,200,000,000 at present at least, and will increase with every speed of doubling in 5 years.U.S.'s statistics of 1988～1994 years show, have 8,000 ten thousand people and suffer from the different obesity of degree, and about 20% the male sex and 25% women obesity cause annual 300000 people dead, and are used for the treatment of the expense of obesity up to 99,000,000,000 dollars every year; Statistical figure table virgin obesity rates tomorrow reached 10% in 1999.Find according to the investigation in 1982～1986 years of MONICA project, the obesity rates in Europe is: the male sex 15%, and the women 22%, and the women is overweight more general than the male sex.In European population between 35～65 years old, overweight or overweight people's ratio reach 38～50% left and right, and Britain is one of fat growth rate the highest country, and in 20 years of the past, adult's fat ratio has increased by 3 times, the Obese children quantity growth 1 times.But the fat increasingly popular America and Europe that is not limited in, in 20 years, the size of population of China, Japan and country in Southeast Asia's Overweight and obesity significantly increases in the past, and in addition, children and Adolescent Obesity problem become increasingly conspicuous.In China, due to growth in the living standard, the obesity incidence of disease sharply rises.Learn from first international fat-reducing conference of Held In Beijing, China adult overweight ratio approximately 20%～30%, the big city has reached 35%～40%, in past 10 years, in the Students ' Obesity patient, the schoolgirl rises to 7% from 3%, the boy student rises to 8% from 2%, and overweight number is 3～4 times of fat number.
China's obese people reaches 7,000 ten thousand, is 14.6% of adult's sum, and wherein areas of Beijing had 930,000 people that obesity occurs in 15～54 years old in the crowd, 900,000,000 yuan of whole city's diet products market capacitys.In prediction on such basis, whole nation fat-reducing market capacity should be 67,700,000,000 yuan, and the year of fat-reducing at present sells less than 10,000,000,000 yuan.The Chinese weight-reducing product market of 21 century mainly can be summed up as healthcare food, teas, drug class, topical class, instrument class.Due to the tangled warfare of China's fat-reducing class health products through nearly 10 years, so far also there is no to form more ripe market brand, the strong lock of some novel health foods enters the market, with its pharmacology of science comparatively, become a kind of Main Means of weight reducing treatments, although " only represent the sub-fraction of overall process ", due to evident in efficacy and praised highly by great majority fat-reducing personage, market potential is huge.
For this reason, develop the health food with weight losing function and have good market prospects.
Summary of the invention
Purpose of the present invention be exactly a kind of synergy pattern that has adopted too many levels, many target position is provided in order to overcome the defective that above-mentioned prior art exists have health products of weight losing function and preparation method thereof.
Purpose of the present invention can be achieved through the following technical solutions:
A kind of health products with weight losing function, the raw material of these health products comprise following component and weight portion content:
Chia extract 20-40;
Oat extract 20-30;
Grape extract 5-15;
Coarse tea extract 5-15;
Thallus Laminariae (Thallus Eckloniae) extract 5-15;
Water-soluble denaturation cornstarch 10-20.
The preferred following component of the raw material of these health products and weight portion content: chia extract 30, oat extract 25, grape extract 10, coarse tea extract 10, Thallus Laminariae (Thallus Eckloniae) extract 10, water-soluble denaturation cornstarch 15.
Described chia extract adopts following methods to obtain: will owe garden-sage and insert in pulverizer, broken 40 mesh sieves of crossing add in its volume 8-10 deionized water doubly, and 60-80 ℃ is extracted 3 times, each 2 hours, the extract concentrate drying is namely obtained the chia extract.
Described oat extract adopts following methods to obtain: oat is joined in its volume 8-10 deionized water doubly, and 60-80 ℃ is extracted 3 times, and each 2 hours, the extract concentrate drying namely obtained oat extract.
Described grape extract adopts following methods to obtain: after the grape fragmentation, joins in its volume 6-8 60-80v/v% ethanolic solution doubly, and 50-60 ℃ of refluxing extraction three times, concentrate drying namely obtains grape extract.
Described coarse tea extract adopts following methods to obtain: coarse tea is joined in its volume 8-10 deionized water doubly, and room temperature is extracted three times, and extract low temperature concentrate drying namely obtains the coarse tea extract.
Described Thallus Laminariae (Thallus Eckloniae) extract adopts following methods to obtain: kelp is joined in its volume 8-10 deionized water doubly, and room temperature is extracted three times, and extract low temperature concentrate drying namely obtains Thallus Laminariae (Thallus Eckloniae) extract.
A kind of preparation method with health products of weight losing function comprises the following steps:
(1) get the raw materials ready according to following component and weight portion content:
Chia extract 20-40,
Oat extract 20-30,
Grape extract 5-15,
Coarse tea extract 5-15,
Thallus Laminariae (Thallus Eckloniae) extract 5-15,
Water-soluble denaturation cornstarch 10-20;
(2) each component in proportion after weighing, is inserted in mixer, mixed 15 minutes, cross 40 mesh sieves, repeat above 3 techniques, the product that obtains carries out compressing tablet by the requirement of production formulation or filled capsules gets final product.
Compared with prior art, the present invention has adopted the synergy pattern of too many levels, many target position to design prescription for losing weight, makes product make every effort to reach effect of weight reducing preferably, and meets the World Health Organization proposes do not suffer from diarrhoea, do not go on a diet and not weak fat-reducing principle.In addition, our product also has the moisture of skin of improvement function when having weight losing function, is better consumer's service.
The specific embodiment
The present invention is described in detail below in conjunction with specific embodiment.
Embodiment 1
Determining of research and development of products thinking
Fat formation reason
Fat formation reason has a lot, mainly comprises: dietary factor, endocrine factors (leptin resistance, insulin resistance), familial inheritance etc.
Dietary factor: higher fatty acid, high caloric diet is on the direct impact of being formed with of obesity, and this is confirmed by animal and human research.Can say for certain that the overweight people all has feed too much, but without absolute quantitative criteria.The absorption of normal adult energy and expenditure long term maintenance balance keep the human body fat mass constant, keep body weight inconvenience; But if feed too much, makes the energy of absorption surpass the consumption of body, unnecessary energy can be converted into fat, is that body weight increases.
Endocrine factors (leptin resistance, insulin resistance): leptin (leptin) is by Expression of Obese Gene, mainly by a kind of circulating hormone of adipocyte secretion.Leptin is kept the balance of body weight by being combined with the leptin receptor of central nervous system by adjusting energy metabolism, feeding behaviour.Studies show that, in overweight people's peripheral blood, leptin exceeds several times than regular severe one, and in cerebrospinal fluid, leptin content raises and not obvious, thereby causes leptin resistance, makes overweight people's " occupy fat not under ".And but high leptin antagonism insulin is to the effect of liver and adipose tissue, thereby caused insulin resistance.And in musculature, because insulin resistance strengthens, thereby directly bring out impaired glucose tolerance, more increased fat neurological susceptibility.
Therefore, we develop this product, have weight losing function, improve better above-mentioned crowd's quality of life.
Weight losing function
Because the formation of obesity is to be caused by too many levels, multidigit point, multifactor institute, it has comprised the many factors such as diet, endocrine.In addition, the overweight people is overweight not only, and its fat metabolism is also abnormal, and principal character is that plasma triglyceride, T-CHOL, low-density lipoprotein and free-fat acid concentration compared with normal people are high, and hdl concentration reduces.
Over against these characteristics, we have adopted the synergy pattern of too many levels, many target position to design prescription for losing weight, make every effort to reach effect of weight reducing preferably, and make product meet the World Health Organization proposes do not suffer from diarrhoea, do not go on a diet and not weak fat-reducing principle.
At first, the transition of inhibition ectogenous fat is absorbed in body.Its effect link can be divided into two classes: one, for by physisorption, after the absorption such as the fat in enteron aisle, triglycerides, cholesterol, get rid of external, thereby reduce its absorption; Two, for by to fatty enzymeinhibition in intestines, ectogenous fat can't be absorbed by enzymolysis, suppress thereby reach the purpose that the ectogenous fat transition absorbs.
Secondly, the metabolic rate of suitable enhancing overweight people body increases the consumption of its energy, thereby reaches " burning " fat, the effect of fat-reducing.
The 3rd, in the inhibition adipocyte, the activity of lipese, promote the decomposition of fat, reduces the volume of adipocyte, thereby reach the effect that subtracts body fat, fat-reducing.
At last, by reducing triglycerides, T-CHOL, low-density lipoprotein and free-fat acid concentration in overweight people's body, improve hdl concentration, so that overweight people's fat metabolic disturbance is improved, thereby the face of can keeping away as much as possible is by the fat complication of bringing, as: coronary heart disease, hypertension, hyperlipidemia, diabetes, cerebrovas-cularaccident etc.
In the health food of now having criticized out, the product with weight losing function accounts for 3%, nearly 250 kinds of quantity, and it can be divided into following several substantially:
(1) take bread and cheese as formulation: Yan Di and Huang Di, two legendary rulers of remote antiquity lose weight crispy rice, refined Lay limmits etc., taking dose is very large usually.
(2) take the form of tea as formulation: an imperial hall board slim tea, drink happy U.S.A fat slim tea etc. of dispelling of giving birth to, usually take comparatively trouble.
(3) product take capsule and tablet as form mostly contains anthraquinone component, and it can cause diarrhoea, gives to take crowd's life and make troubles.
Two, the screening of health care
1, the formula main ingredient is selected
On the basis of above-mentioned research and development thinking, we filter out by experiment, develop take chia extract, oat extract, grape extract, coarse tea extract, Thallus Laminariae (Thallus Eckloniae) extract and water-soluble denaturation cornstarch as primary raw material.
2, the checking of animal experiment to the formula effect of weight reducing
In order to verify whether this human body taking dose is effective to fat-reducing, we entrust professor Sun Guiju of medical college of Southeast China University this to be carried out the animal experiment checking, test method is with reference to " SFDA fat-reducing animal experiment rules ", and dosage is respectively low dosage human body 5 multiple doses, middle dosage human body 10 multiple doses, high dose human body 30 multiple doses (dividing dosage by the SFDA requirement).Result of the test is as follows.
Table 1 fat-reducing result ()
* dunnett ' s check relatively has significant difference with Normal group, P＜0.05
#dunnett ' s check relatively has significant difference with model control group, P＜0.05
Table 2 fat-reducing result (two)
* dunnett ' s check relatively has significant difference with Normal group, P＜0.05
#dunnett ' s check relatively has significant difference with model control group, P＜0.05
Table 3 fat-reducing result (three)
* dunnett ' s check relatively has significant difference with Normal group, P＜0.05
#dunnett ' s check relatively has significant difference with model control group, P＜0.05
This shows, show after this product empirical tests, this product all has fat-reducing effect in middle and high dosage group.It is when reducing the obese rat body weight, reduced the secretion of adipocyte leptin (leptin), reduce the level of Serum Leptin Levels, improved simultaneously the level of hypothalamic leptin receptors bind leptin, thereby improved the level of leptin in the hypothalamus, thereby brought into play the effect that it controls body weight, fat-reducing.
What 4, formula was final determines
| Material name | ％ |
| The chia extract | 30 |
| Oat extract | 25 |
| Grape extract | 10 |
| The coarse tea extract | 10 |
| Thallus Laminariae (Thallus Eckloniae) extract | 10 |
| Water-soluble denaturation cornstarch | 15 |
Embodiment 2
A kind of health products with weight losing function, the raw material of these health products comprises following component and content: chia extract 20kg, oat extract 20kg, grape extract 5kg, coarse tea extract 5kg, Thallus Laminariae (Thallus Eckloniae) extract 5kg, water-soluble denaturation cornstarch 10kg.
The chia extract adopts following methods to obtain: will owe garden-sage and insert in pulverizer, broken 40 mesh sieves of crossing add in the deionized water of 8 times of its volumes, and 60 ℃ are extracted 3 times, each 2 hours, the extract concentrate drying is namely obtained the chia extract.Oat extract adopts following methods to obtain: oat is joined in the deionized water of 8 times of its volumes, 60 ℃ are extracted 3 times, and each 2 hours, the extract concentrate drying namely obtained oat extract.Grape extract adopts following methods to obtain: after the grape fragmentation, joins in the 60v/v% ethanolic solution of 6 times of its volumes, and 50 ℃ of refluxing extraction three times, concentrate drying namely obtains grape extract.The coarse tea extract adopts following methods to obtain: coarse tea is joined in the deionized water of 8 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains the coarse tea extract.Thallus Laminariae (Thallus Eckloniae) extract adopts following methods to obtain: kelp is joined in the deionized water of 8 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains Thallus Laminariae (Thallus Eckloniae) extract.
Each component in proportion after weighing, is inserted in mixer, mixed 15 minutes, cross 40 mesh sieves, repeat above 3 techniques, the product that obtains carries out compressing tablet by the requirement of production formulation or filled capsules gets final product.
Embodiment 3
A kind of health products with weight losing function, the raw material of these health products comprises following constituent content: chia extract 30kg, oat extract 25kg, grape extract 10kg, coarse tea extract 10kg, Thallus Laminariae (Thallus Eckloniae) extract 10kg, water-soluble denaturation cornstarch 15kg.
The chia extract adopts following methods to obtain: will owe garden-sage and insert in pulverizer, broken 40 mesh sieves of crossing add in the deionized water of 9 times of its volumes, and 70 ℃ are extracted 3 times, each 2 hours, the extract concentrate drying is namely obtained the chia extract.Oat extract adopts following methods to obtain: oat is joined in the deionized water of 9 times of its volumes, 70 ℃ are extracted 3 times, and each 2 hours, the extract concentrate drying namely obtained oat extract.Grape extract adopts following methods to obtain: after the grape fragmentation, joins in the 70v/v% ethanolic solution of 7 times of its volumes, and 50 ℃ of refluxing extraction three times, concentrate drying namely obtains grape extract.The coarse tea extract adopts following methods to obtain: coarse tea is joined in the deionized water of 9 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains the coarse tea extract.Thallus Laminariae (Thallus Eckloniae) extract adopts following methods to obtain: kelp is joined in the deionized water of 9 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains Thallus Laminariae (Thallus Eckloniae) extract.
Each component in proportion after weighing, is inserted in mixer, mixed 15 minutes, cross 40 mesh sieves, repeat above 3 techniques, the product that obtains carries out compressing tablet by the requirement of production formulation or filled capsules gets final product.
Embodiment 4
A kind of health products with weight losing function, the raw material of these health products comprises following component and content: chia extract 40kg, oat extract 30kg, grape extract 15kg, coarse tea extract 15kg, Thallus Laminariae (Thallus Eckloniae) extract 15kg, water-soluble denaturation cornstarch 20kg.
The chia extract adopts following methods to obtain to owe garden-sage and inserts in pulverizer, and broken 40 mesh sieves of crossing add in the deionized water of 10 times of its volumes, and 80 ℃ are extracted 3 times, each 2 hours, the extract concentrate drying namely obtained the chia extract.Oat extract adopts following methods to obtain: oat is joined in the deionized water of 10 times of its volumes, 80 ℃ are extracted 3 times, and each 2 hours, the extract concentrate drying namely obtained oat extract.Grape extract adopts following methods to obtain: after the grape fragmentation, joins in the 80v/v% ethanolic solution of 8 times of its volumes, and 60 ℃ of refluxing extraction three times, concentrate drying namely obtains grape extract.The coarse tea extract adopts following methods to obtain: coarse tea is joined in the deionized water of 10 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains the coarse tea extract.Thallus Laminariae (Thallus Eckloniae) extract adopts following methods to obtain: kelp is joined in the deionized water of 10 times of its volumes, room temperature is extracted three times, and extract low temperature concentrate drying namely obtains Thallus Laminariae (Thallus Eckloniae) extract.
Each component in proportion after weighing, is inserted in mixer, mixed 15 minutes, cross 40 mesh sieves, repeat above 3 techniques, the product that obtains carries out compressing tablet by the requirement of production formulation or filled capsules gets final product.
Claims (2)
1. the health products with weight losing function, is characterized in that, the raw material of these health products comprises following component and weight portion content:
Chia extract 20-40;
Oat extract 20-30;
Grape extract 5-15;
Coarse tea extract 5-15;
Thallus Laminariae (Thallus Eckloniae) extract 5-15;
Water-soluble denaturation cornstarch 10-20;
Described chia extract adopts following methods to obtain: chia is inserted in pulverizer, broken 40 mesh sieves of crossing add in its volume 8-10 deionized water doubly, and 60-80 ℃ is extracted 3 times, each 2 hours, the extract concentrate drying is namely obtained the chia extract;
Described oat extract adopts following methods to obtain: oat is joined in its volume 8-10 deionized water doubly, and 60-80 ℃ is extracted 3 times, and each 2 hours, the extract concentrate drying namely obtained oat extract;
Described grape extract adopts following methods to obtain: after the grape fragmentation, joins in its volume 6-8 60-80v/v% ethanolic solution doubly, and 50-60 ℃ of refluxing extraction three times, concentrate drying namely obtains grape extract;
Described coarse tea extract adopts following methods to obtain: coarse tea is joined in its volume 8-10 deionized water doubly, and room temperature is extracted three times, and extract low temperature concentrate drying namely obtains the coarse tea extract;
Described Thallus Laminariae (Thallus Eckloniae) extract adopts following methods to obtain: kelp is joined in its volume 8-10 deionized water doubly, and room temperature is extracted three times, and extract low temperature concentrate drying namely obtains Thallus Laminariae (Thallus Eckloniae) extract.
2. a kind of health products with weight losing function according to claim 1, it is characterized in that the preferred following component of the raw material of these health products and weight portion content: chia extract 30, oat extract 25, grape extract 10, coarse tea extract 10, Thallus Laminariae (Thallus Eckloniae) extract 10, water-soluble denaturation cornstarch 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100670428A CN102599502B (en) | 2012-03-14 | 2012-03-14 | Healthcare product with weight reducing function and preparation method of healthcare product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100670428A CN102599502B (en) | 2012-03-14 | 2012-03-14 | Healthcare product with weight reducing function and preparation method of healthcare product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102599502A CN102599502A (en) | 2012-07-25 |
| CN102599502B true CN102599502B (en) | 2013-06-26 |
Family
ID=46517578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100670428A Active CN102599502B (en) | 2012-03-14 | 2012-03-14 | Healthcare product with weight reducing function and preparation method of healthcare product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102599502B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103598494B (en) * | 2013-10-30 | 2015-01-07 | 界首市东亚淀粉出品有限公司 | Edible modified starch with fat-reducing efficacy |
| CN104273531A (en) * | 2014-10-11 | 2015-01-14 | 中山百鸥医药科技有限公司 | Preparation method of health food with fat-losing function |
| CN105231199A (en) * | 2015-09-16 | 2016-01-13 | 安徽阜南常晖食品有限公司 | Fat eliminating and health preserving sweet orange drink |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121791A (en) * | 1994-10-25 | 1996-05-08 | 何继梅 | Zipper mosquito net |
| CN100998411A (en) * | 2006-12-18 | 2007-07-18 | 东北虎药业股份有限公司 | Health-care food with anti-oxidation and lowering weight functions |
-
2012
- 2012-03-14 CN CN2012100670428A patent/CN102599502B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121791A (en) * | 1994-10-25 | 1996-05-08 | 何继梅 | Zipper mosquito net |
| CN100998411A (en) * | 2006-12-18 | 2007-07-18 | 东北虎药业股份有限公司 | Health-care food with anti-oxidation and lowering weight functions |
Non-Patent Citations (2)
| Title |
|---|
| 胡忠红等.芡欧鼠尾草脂肪酸成分分析.《中国粮油学报》.2011,第26卷(第12期),106-108. |
| 芡欧鼠尾草脂肪酸成分分析;胡忠红等;《中国粮油学报》;20111231;第26卷(第12期);106-108 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102599502A (en) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102613555B (en) | Maca powder and ginseng composition and preparation method thereof | |
| Dharmananda | The Nature of Ginseng from Traditional Use to Modern Research | |
| US7927633B2 (en) | Adaptogenic tea | |
| Sukandar et al. | Antiobesity effect of ethanol extract of Anredera cordifolia (Ten.) Steenis leaves on obese male wistar rats induced by high_carbohydrate diet | |
| CN101062080B (en) | Medicinal composition for relieving fatigue and preparing process thereof | |
| CN101890125B (en) | Medicine for treating hyperthyroidism and preparation method thereof | |
| CN104206949A (en) | Composition for improving osteoporosis and increasing bone mineral density, preparation method of same and application of the same in preparation of health-caring product | |
| CN102599502B (en) | Healthcare product with weight reducing function and preparation method of healthcare product | |
| Bhat et al. | Antilipidemic activity of arecanut, Areca catechu L.: A valuable herbal medicine | |
| CN109820959A (en) | A kind of dendrobium candidum extract and its application rich in flavone c-glycoside | |
| CN104703616A (en) | Formulations for the treatment and prevention of obesity | |
| CN108186877A (en) | For the Chinese medicine composition of syndrome of blood stasis due to qi deficiency myocardial infarction secondary prevention | |
| CN102726557A (en) | Food possessing auxiliary hypolipidemic function | |
| CN102552574A (en) | Health-care medicine formula with weight-losing function | |
| CN103610051A (en) | Food, healthcare food or medicine composition with lipid-lowering effect as well as preparation methods and applications thereof | |
| CN103393097A (en) | Health food with effects of sobering and protecting liver | |
| Liu et al. | Network pharmacology combined with an animal model to reveal the material basis and mechanism of Amomum villosum in alleviating constipation in mice | |
| CN102228111A (en) | Health-care tea capable of assisting diabetes treatment and preparation method thereof | |
| CN102335251A (en) | Composition with effect of relieving alcoholism, and preparation method thereof | |
| CN101558876A (en) | Raspberry health product and preparation technique thereof | |
| CN103705578A (en) | Traditional Chinese medicine preparation with functions of reducing blood fat and inhibiting blood glucose increase and preparation method thereof | |
| CN103735697A (en) | Chinese medicinal preparation having gout-resisting effect and preparation method thereof | |
| CN103525640B (en) | Energy-keeping yang-tonifying wine | |
| Lubis et al. | An Effect Of Methanol Extract Sunkist Orange Peel (Citrus Sinensis (L.) Osbeck) On Blood Sugar And Cholesterol Levels Wistar Rats (Rattus Norvegicus) Induced By Aloxan | |
| CN105963595A (en) | Auxiliary uric acid reducing tablet with antrodia camphorata and method for preparing auxiliary uric acid reducing tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150917 Address after: 200072, room 6, building 201, Yonghe Road, Shanghai, Zhabei District, 201-3 Patentee after: Shanghai Shanlijian Biotechnology Co.,Ltd. Address before: 200072, room 6, building 201, Yonghe Road, Shanghai, Zhabei District, 201-2 Patentee before: Shanghai Shanlijian Health-care Food Co., Ltd. |